Literature DB >> 15138207

Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone.

A Charlton1, V Blair, D Shaw, S Parry, P Guilford, I G Martin.   

Abstract

BACKGROUND AND AIMS: Germline mutations in the CDH-1/E-cadherin gene are, to date, the only known cause of hereditary diffuse gastric cancer (HDGC). While two recent series of prophylactic gastrectomy described microscopic foci of signet ring cell carcinoma in sample sections from 10 macroscopically normal stomachs, whole stomach phenotype has not been mapped. We aimed to describe the size and distribution of foci in relation to mucosal zones and anatomical location.
METHODS: Six patients (from three HDGC kindred) were referred for total gastrectomy via three different referral pathways. Following fixation, five stomachs were completely blocked and one extensively sampled. Histopathology was mapped to a mucosal photograph of each stomach, enabling precise localisation of carcinoma foci, benign pathology, and mucosal zones.
RESULTS: There were 4-318 microscopic foci of intramucosal signet ring cell adenocarcinoma in the six macroscopically normal stomachs (foci size 0.1-10 mm in diameter). The distal third of the stomach contained 48% of total foci (range 29-75%). The body-antral transitional zone occupied 7.7% of mucosal area (range 3.6-11.8) but had 37% of foci (range 10%-75%). The largest foci were found in the transitional zone and foci density was five times greater in the transitional zone than in body or antral type mucosa.
CONCLUSIONS: In germline CDH-1 mutation carriers, multiple microscopic foci of intramucosal signet ring cell carcinoma show a predilection for the distal stomach and the body-antral transitional zone. Targeting the transitional zone would maximise the likelihood of finding foci in macroscopically normal gastrectomies, and particular attention should be paid to this area during endoscopy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138207      PMCID: PMC1774074          DOI: 10.1136/gut.2002.010447

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  Hereditary diffuse gastric cancer: more answers or more questions?

Authors:  William M Grady; Richard M Peek
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

2.  Loss of E-cadherin is the fundamental defect in diffuse-type gastric carcinoma and infiltrating lobular carcinoma of the breast.

Authors:  J K Chan; C S Wong
Journal:  Adv Anat Pathol       Date:  2001-05       Impact factor: 3.875

Review 3.  The gastric transitional zones: neglected links between gastroduodenal pathology and helicobacter ecology.

Authors:  S J Van Zanten; M F Dixon; A Lee
Journal:  Gastroenterology       Date:  1999-05       Impact factor: 22.682

Review 4.  Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?

Authors:  Y S Chun; N M Lindor; T C Smyrk; B T Petersen; L J Burgart; P J Guilford; J H Donohue
Journal:  Cancer       Date:  2001-07-01       Impact factor: 6.860

5.  Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.

Authors:  D G Huntsman; F Carneiro; F R Lewis; P M MacLeod; A Hayashi; K G Monaghan; R Maung; R Seruca; C E Jackson; C Caldas
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

6.  A possible dual control mechanism in the origin of peptic ulcer. A study on ulcer location as affected by mucosa and musculature.

Authors:  M Oi; Y Ito; F Kumagai; K Yoshida; Y Tanaka; K Yoshikawa; O Miho; M Kijima
Journal:  Gastroenterology       Date:  1969-09       Impact factor: 22.682

7.  Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families.

Authors:  P D Pharoah; P Guilford; C Caldas
Journal:  Gastroenterology       Date:  2001-12       Impact factor: 22.682

8.  Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer.

Authors:  W M Grady; J Willis; P J Guilford; A K Dunbier; T T Toro; H Lynch; G Wiesner; K Ferguson; C Eng; J G Park; S J Kim; S Markowitz
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

9.  Evaluation of gastric acid secretion at endoscopy with a modified Congo red test.

Authors:  Ervin Tóth; Kristina Sjölund; Ola Thorsson; Henrik Thorlacius
Journal:  Gastrointest Endosc       Date:  2002-08       Impact factor: 9.427

10.  Immunohistochemical investigation of gastrin-producing cells (G cells). Estimation of antral density, mucosal distribution, and total mass of G cells in resected stomachs from patients with peptic ulcer disease.

Authors:  R Stave; P Brandtzaeg
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

View more
  43 in total

Review 1.  A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.

Authors:  Rajini Seevaratnam; Natalie Coburn; Roberta Cardoso; Matthew Dixon; Alina Bocicariu; Lucy Helyer
Journal:  Gastric Cancer       Date:  2011-12-10       Impact factor: 7.370

2.  Familial gastric cancer: update for practice management.

Authors:  Giovanni Corso; Daniele Marrelli; Franco Roviello
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

Review 3.  [Prophylactic gastric surgery].

Authors:  H Vogelsang; K Ott; J Mehler; G Keller; J R Siewert
Journal:  Chirurg       Date:  2005-12       Impact factor: 0.955

Review 4.  Recognition of and recent issues in hereditary diffuse gastric cancer.

Authors:  Shinya Sugimoto; Hirokazu Komatsu; Yuichi Morohoshi; Takanori Kanai
Journal:  J Gastroenterol       Date:  2015-06-07       Impact factor: 7.527

5.  Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?

Authors:  D Shaw; V Blair; A Framp; P Harawira; M McLeod; P Guilford; S Parry; A Charlton; I Martin
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

6.  Endoscopic estimation of tumor size in early gastric cancer.

Authors:  Jeongmin Choi; Sang Gyun Kim; Jong Pil Im; Joo Sung Kim; Hyun Chae Jung
Journal:  Dig Dis Sci       Date:  2013-04-16       Impact factor: 3.199

7.  Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.

Authors:  David J Degraff; Adam A Aguiar; Robert A Sikes
Journal:  Am J Transl Res       Date:  2009-01-20       Impact factor: 4.060

Review 8.  Preemptive surgery for premalignant foregut lesions.

Authors:  Rohit R Sharma; Mark J London; Laura L Magenta; Mitchell C Posner; Kevin K Roggin
Journal:  J Gastrointest Surg       Date:  2009-06-10       Impact factor: 3.452

9.  Clinical implications of E-cadherin associated hereditary diffuse gastric cancer.

Authors:  R C Fitzgerald; C Caldas
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

10.  A short guide to hereditary diffuse gastric cancer.

Authors:  Parry Guilford; Vanessa Blair; Helen More; Bostjan Humar
Journal:  Hered Cancer Clin Pract       Date:  2007-12-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.